Gestational trophoblastic neoplasia Flashcards
Gestational trophoblastic neoplasia
very rare
invasive mole - hydatidiform mole/molar pregnancy
choriocarcinoma
Etiology of gestational trophoblastic neoplasia
can occur after any pregnancy
usually after non-malignant GTN
Natural Hx of gestational trophoblastic neoplasia
hemorrahge
metastasis
preeclampsia, etc
Spread of gestational trophoblastic neoplasia
via blood lungs 80% pelvis 30% vagina 20% brain/liver 10% bowel, kidney, spleen
SSx of gestational trophoblastic neoplasia
large for date pregnancy bleeding nausea no fetal HR Preeclampsia: 27% historically, now 1-2% Theca lutein cysts Hyperthyroidism: chorionic gonadotropin bears structural homology to pit thyrotropin 1
Dx of gestational trophoblastic neoplasia
US
very high betahCG
metastatic signs: blood test for kidney, liver, bone, anemia, etc
Imaging: lungs, head, abdomen, pelvis
Staging of gestational trophoblastic neoplasia
beta hCG
imaging
Tx of gestational trophoblastic neoplasia
D&C
possible chemotherapy for rising betahCG, invasive disease
Followup of gestational trophoblastic neoplasia
monthly betahCG
contraception 1 year
early ultrasound and betahCG in next pregnancy
Prognosis of gestational trophoblastic neoplasia (malignant)
very good: 95% 5 year
fertility unchanged
High risk prognosis: 5 Fs antecedent Full term pregnancy Far away mets bhCG> 40,000 Failed low risk chemo >4 mo since pregnancy
Hydatidiform mole
Empty ovum fertilized by a haploid sperm then 2x
- -> ovum nucleus deactivated/absent
- -> entirely paternal origin in complete mole
- trophoblast proliferates only
Pregnancy with no embryo but cystic degeneration of chorionic villi
Incidence of GTD
Hydatidiform mole 1:1000
Invasive 1:10000
Placental site trophoblastic tumour: 1:20000
Choriocarcinoma: 1:40000
Normal placenta biochemical markers
Syncytiotrophoblast - hCG, hPL
Intermediate trophoblast –> hPL
Cytotrophoblast - none
Risk factors for GTD/molar pregnancy
Extremes of maternal age (40)
Previous molar pregnancy - 1-2%
?Dietary ?geographical factors
Complete mole
diffuse hydatidiform swelling
difuse trophoblastic hyperplasia
No fetal tissue
Karyotype: 2 paternal haploid - 46XX, XY
Partial mole
Focal hydatidiform swelling
focal trophoblastic hyperplasia
fetal tissue present
Karyotype: 2 paternal + 1 maternal haploid, 69 XXY, XYY
Investigations of GTD
Diagnostic imaging: US classic snowstorm pattern Lab: CBC bhCG - high thyroid liver function tests (mets) renal function (prior to chemo)
Management of GTD
CXR - metastatic workup; spreads to lungs first
Dilatation/suction - risk for massive hemorrhage so need to evacuate ASAP
betahCG weekly until normal x3 and then monthly for a year
6-12 mo
Average time to normalcy 9-11 wks
Contraception 6-12 mo
- Need to follow up betahCG; CANNOT get pregnant!!
Danger of GTD
Invasive mole: 15-20% of complete moles; 2-4% of partial moles
Choriocarcinoma: extremely malignant form
Placental site trophoblastic tumour: rare
Symptoms/signs of malignant GTD
elevated betahCG but not pregnant
vaginal bleeding
metastatic disease - cerebral, abdominal, pulmonary bleeding
consider GTD in differential in reproductive age woman with systemic disease
Management of low risk malignant GTD
Single Agent Chemo - methotrexate, actinomycin D
Combination Chemo: methotrexate + actinomycin D
90% remission
Management of high risk GTD
Combination chemo
- MAC
- VPB
- EMA-CO